Medicare Enrolled

Dr. Julie Huh, MD

Obstetrics & Gynecology · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2100 WEBSTER ST, San Francisco, CA 94115
4159233123
In practice since 2005 (20 years)
NPI: 1225026446 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Huh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Huh

Dr. Julie Huh is an obstetrics & gynecology specialist in San Francisco, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Huh performed 159 Medicare services across 149 unique beneficiaries.

Between the years covered by Open Payments, Dr. Huh received a total of $4,127 from 40 pharmaceutical and/or device companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Huh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 35% volume in CA $4,127 industry payments

Medicare Practice Summary

Medicare Utilization ↗
159
Medicare services
Top 35% in CA for obstetrics & gynecology
149
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Fecal immunochemical test (FIT), 1-3 simultaneous
A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer.
36 $18 $44
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $72 $166
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
31 $47 $87
Pap smear screening test
A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis.
30 $55 $109
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
14 $193 $389
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
14 $153 $314
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,127
Total received (2018-2024)
Avg $590/year across 7 years
Top 12% in CA for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
210
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,037 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$270
2023
$339
2022
$703
2021
$909
2020
$438
2019
$687
2018
$780

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
MAYNE PHARMA COMMERCIAL LLC
$79
Organon Llc
$79
ABBVIE INC.
$47
Hologic Sales and Service, LLC
$43
Amgen Inc.
$22
Top 3 companies account for 75.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$405
Merck Sharp & Dohme Corporation
$301
Avion Pharmaceuticals
$281
CooperSurgical, Inc.
$277
ABBVIE INC.
$272
AbbVie Inc.
$255
Bayer HealthCare Pharmaceuticals Inc.
$247
TherapeuticsMD, Inc.
$240
Hologic, LLC
$156
Organon LLC
$150
AbbVie, Inc.
$148
MAYNE PHARMA COMMERCIAL LLC
$133
Vertical Pharmaceuticals, LLC
$124
Roche Diagnostics Corporation
$96
AMAG Pharmaceuticals, Inc.
$90
MAYNE PHARMA INC.
$87
Organon Llc
$79
ASCEND Therapeutics US, LLC
$78
PFIZER INC.
$78
Sage Therapeutics, Inc.
$58
Mycovia Pharmaceuticals, Inc.
$54
Lupin Inc.
$53
Myovant Sciences Inc.
$43
Hologic Sales and Service, LLC
$43
Allergan Inc.
$39
Mallinckrodt LLC
$37
Evofem Biosciences, Inc.
$34
Dilon Technologies, Inc.
$32
Astellas Pharma US Inc
$25
Mylan Pharmaceuticals Inc.
$24
SANOFI PASTEUR INC.
$24
ASCEND THERAPEUTICS US, LLC
$23
Olympus America Inc.
$22
Xeris Pharmaceuticals, Inc.
$21
Agile Therapeutics, Inc.
$19
Vermillion, Inc.
$17
Pacira Pharmaceuticals Incorporated
$17
Minerva Surgical, Inc
$17
Duchesnay USA Incorporated
$16
Channel Medsystems, Inc.
$13
Top 3 companies account for 23.9% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · ANNOVERA · Aptima Combo 2 · Aptima HPV · BINOSTO · Balcoltra · Bonjesta · Co testing · DIVIGEL · Divigel · ESTROGEL · EVENITY · EXPAREL · Endosee · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GARDASIL 9 · GVOKE PFS · HEMOBLAST BELLOWS · IMVEXXY · INTRAROSA · JADA SYSTEM · Kyleena · LILETTA · LO LOESTRIN FE · Lupron · MAKENA · METHERGINE · MYFEMBREE · MYOSURE TISSUE REMOVAL DEVICE · Mirena · NEXPLANON · NOVASURE · NUVARING · OFIRMEV · ORIAHNN · ORILISSA · OSMOLEX ER · OVA1 · Olympus Resection Disposables · Orilissa · Other Gyn Products · PREMARIN · Paragard · Phexxi · Prenate Mini · Prolia · RS Harmony Test Related Products · SOLOSEC · THINPREP 2000 PROCESSOR · Thin Prep · ThinPrep · Twirla · Veozah · Vivjoa · Xulane · ZULRESSO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an obstetrics & gynecology specialist in San Francisco?
Compare obstetricians & gynecologists in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
659
Per 100K population
78.8
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Huh is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Huh experienced with fecal immunochemical test (fit), 1-3 simultaneous?
Based on Medicare claims data, Dr. Huh performed 36 fecal immunochemical test (fit), 1-3 simultaneous services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huh receive payments from pharmaceutical companies?
Yes. Dr. Huh received a total of $4,127 from 40 companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huh's costs compare to other obstetricians & gynecologists in San Francisco?
Dr. Huh's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →